Clinical Trial Update: Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 device trial evaluating Contak Renewal 2 and Easytrak 2 for congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Contak Renewal 2
• Easytrak 2

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Congestive Heart Failure | Phase 2, Phase 3 | Status: COMPLETED